Number | Date | Country | Kind |
---|---|---|---|
57-101940 | Jun 1982 | JPX | |
428192 | May 1983 | CAX | |
1149/83 | May 1983 | IEX | |
83/3521 | May 1983 | ZAX | |
522489 | May 1983 | ESX | |
48327 A/83 | May 1983 | ITX |
This application is a continuation-in-part of my earlier copending applications Ser. No. 379,316, filed May 18, 1982, now U.S. Pat. No. 4,449,932, filed Jan. 27, 1983, abandoned in favor of Ser. No. 733,463, filed May 13, 1985; Ser. No. 475,493, filed Mar. 15, 1983, now U.S. Pat. No. 4,622,218 and Ser. No. 516,382, filed July 22, 1983, now U.S. Pat. No. 4,540,564. Each of said earlier copending applications is hereby expressly incorporated by reference herein in its entirety and relied upon.
Number | Name | Date | Kind |
---|---|---|---|
3338969 | Muller et al. | Aug 1967 | |
3413314 | Amiard et al. | Nov 1968 | |
3962447 | Higuchi et al. | Jun 1976 | |
4035507 | Bodor et al. | Jul 1977 | |
4057561 | Furst et al. | Nov 1977 | |
4065566 | Bodor et al. | Dec 1977 | |
4479932 | Bodor | Oct 1984 | |
4540564 | Bodor | Sep 1985 |
Entry |
---|
Bodor et al., Science 190, 155-156 (1975). |
Shek et al., J. Med. Chem. 19, 113-117 (1976). |
Bodor et al., in Design of Biopharmaceutical Properties through Prodrugs and Analogs, ed. Edward B. Roche, American Pharmaceutical Association, Washington, D.C. 98-135 (1977). |
Bodor et al. J. Pharm. Sci. 67, 685-687 (1978). |
Bodor et al., Science 214, 1370-1372 (1981). |
Brewster III, Dis. Abst. Int. B., vol. 43, #9, p. 2910 B (1983). |
Bodor et al., J. Med. Chem. 26, 313-318 (1983). |
Bodor et al., J. Med. Chem. 26, 528-534 (1983). |
Bodor et al., Pharmac. Ther. 19, 337-386 (1983). |
Bodor et al., J. Pharm. Sci. 73, 385-389 (1984). |
Bodor et al., Science 221, 65-67 (1983). |
Chemical and Engineering News, Dec. 21, 1981, 24-25. |
Science News, Jan. 2, 1982, vol. 121, No. 1, p. 7. |
Number | Date | Country | |
---|---|---|---|
Parent | 665940 | Oct 1984 |
Number | Date | Country | |
---|---|---|---|
Parent | 379316 | May 1982 |